Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | HD105 |
Synonyms | |
Therapy Description |
HD105 is a bi-specific antibody that targets VEGF and DLL4, resulting in decreased ligand-receptor binding and potentially leading to reduced tumor progression (PMID: 27049350). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HD105 | DLL4 Antibody 7 VEGF Antibody 11 | HD105 is a bi-specific antibody that targets VEGF and DLL4, resulting in decreased ligand-receptor binding and potentially leading to reduced tumor progression (PMID: 27049350). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|